Chromosomal translocations juxtaposing the MYC protooncogene with regulatory sequences of immunoglobulin (Ig) H chain or kappa (Igκ) or lambda (Igλ) L chain genes and effecting deregulated expression of MYC are the hallmarks of human Burkitt lymphoma (BL). Here we report that lymphomas with striking similarities to BL develop in mice bearing a mutated human MYC gene controlled by a reconstructed Igλ locus encompassing all the elements required for establishment of locus control in vitro. Diffusely infiltrating lymphomas with a typical starry sky appearance occurred in multiple founders and an established line, indicating independence from positional effects. Monoclonal IgM+CD5−CD23− tumors developed from an initially polyclonal population of B cells. These results demonstrate that the phenotype of B lineage lymphomas induced by MYC dysregulation is highly dependent on cooperativity among the regulatory elements that govern expression of the protooncogene and provide a new system for studying the pathogenesis of BL.
Skip Nav Destination
Article navigation
16 October 2000
Brief Definitive Report|
October 16 2000
Burkitt Lymphoma in the Mouse
Alexander L. Kovalchuk,
Alexander L. Kovalchuk
aLaboratory of Genetics, National Cancer Institute,
Search for other works by this author on:
Chen-Feng Qi,
Chen-Feng Qi
bLaboratory of Immunopathology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892
Search for other works by this author on:
Ted A. Torrey,
Ted A. Torrey
bLaboratory of Immunopathology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892
Search for other works by this author on:
Lekidelu Taddesse-Heath,
Lekidelu Taddesse-Heath
bLaboratory of Immunopathology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892
Search for other works by this author on:
Lionel Feigenbaum,
Lionel Feigenbaum
cScience Applications International Corporation (SAIC), Frederick Cancer Research Center, National Cancer Institute, National Institutes of Health, Frederick, Maryland 21702
Search for other works by this author on:
Sung Sup Park,
Sung Sup Park
aLaboratory of Genetics, National Cancer Institute,
Search for other works by this author on:
Armin Gerbitz,
Armin Gerbitz
dInstitut für Klinische Molekularbiologie und Tumorgenetik, Munich 81377, Germany
Search for other works by this author on:
Gustav Klobeck,
Gustav Klobeck
eInstitut für Physiologische Chemie der Ludwig-Maximilian Universität, Munich 80336, Germany
Search for other works by this author on:
Konstanze Hoertnagel,
Konstanze Hoertnagel
dInstitut für Klinische Molekularbiologie und Tumorgenetik, Munich 81377, Germany
Search for other works by this author on:
Axel Polack,
Axel Polack
dInstitut für Klinische Molekularbiologie und Tumorgenetik, Munich 81377, Germany
Search for other works by this author on:
Georg W. Bornkamm,
Georg W. Bornkamm
dInstitut für Klinische Molekularbiologie und Tumorgenetik, Munich 81377, Germany
Search for other works by this author on:
Siegfried Janz,
Siegfried Janz
aLaboratory of Genetics, National Cancer Institute,
Search for other works by this author on:
Herbert C. Morse, III
Herbert C. Morse, III
bLaboratory of Immunopathology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892
Search for other works by this author on:
Alexander L. Kovalchuk
aLaboratory of Genetics, National Cancer Institute,
Chen-Feng Qi
bLaboratory of Immunopathology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892
Ted A. Torrey
bLaboratory of Immunopathology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892
Lekidelu Taddesse-Heath
bLaboratory of Immunopathology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892
Lionel Feigenbaum
cScience Applications International Corporation (SAIC), Frederick Cancer Research Center, National Cancer Institute, National Institutes of Health, Frederick, Maryland 21702
Sung Sup Park
aLaboratory of Genetics, National Cancer Institute,
Armin Gerbitz
dInstitut für Klinische Molekularbiologie und Tumorgenetik, Munich 81377, Germany
Gustav Klobeck
eInstitut für Physiologische Chemie der Ludwig-Maximilian Universität, Munich 80336, Germany
Konstanze Hoertnagel
dInstitut für Klinische Molekularbiologie und Tumorgenetik, Munich 81377, Germany
Axel Polack
dInstitut für Klinische Molekularbiologie und Tumorgenetik, Munich 81377, Germany
Georg W. Bornkamm
dInstitut für Klinische Molekularbiologie und Tumorgenetik, Munich 81377, Germany
Siegfried Janz
aLaboratory of Genetics, National Cancer Institute,
Herbert C. Morse, III
bLaboratory of Immunopathology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892
Received:
June 01 2000
Revision Requested:
August 28 2000
Accepted:
August 31 2000
Online ISSN: 1540-9538
Print ISSN: 0022-1007
© 2000 The Rockefeller University Press
2000
The Rockefeller University Press
J Exp Med (2000) 192 (8): 1183–1190.
Article history
Received:
June 01 2000
Revision Requested:
August 28 2000
Accepted:
August 31 2000
Citation
Alexander L. Kovalchuk, Chen-Feng Qi, Ted A. Torrey, Lekidelu Taddesse-Heath, Lionel Feigenbaum, Sung Sup Park, Armin Gerbitz, Gustav Klobeck, Konstanze Hoertnagel, Axel Polack, Georg W. Bornkamm, Siegfried Janz, Herbert C. Morse; Burkitt Lymphoma in the Mouse. J Exp Med 16 October 2000; 192 (8): 1183–1190. doi: https://doi.org/10.1084/jem.192.8.1183
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement